248 related articles for article (PubMed ID: 26476750)
1. Hederagenin as a triterpene template for the development of new antitumor compounds.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Csuk R; Heller L
Eur J Med Chem; 2015 Nov; 105():57-62. PubMed ID: 26476750
[TBL] [Abstract][Full Text] [Related]
2. Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Heller L; Csuk R
Eur J Med Chem; 2016 Jun; 115():257-67. PubMed ID: 27017553
[TBL] [Abstract][Full Text] [Related]
3. Hederagenin amide derivatives as potential antiproliferative agents.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; Ataide Martins JP; Fischer Nee Heller L; Csuk R
Eur J Med Chem; 2019 Apr; 168():436-446. PubMed ID: 30840925
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
Liu XX; Yang YT; Wang X; Wang KY; Liu JQ; Lei L; Luo XM; Zhai R; Fu FH; Wang HB; Bi Y
Eur J Med Chem; 2017 Dec; 141():427-439. PubMed ID: 29040953
[TBL] [Abstract][Full Text] [Related]
5. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity evaluation of novel oleanolic acid derivatives.
Meng YQ; Zhao YW; Kuai ZY; Liu LW; Li W
J Asian Nat Prod Res; 2017 Oct; 19(10):1000-1010. PubMed ID: 28140665
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and proapoptotic activity of oleanolic acid derived amides.
Heller L; Knorrscheidt A; Flemming F; Wiemann J; Sommerwerk S; Pavel IZ; Al-Harrasi A; Csuk R
Bioorg Chem; 2016 Oct; 68():137-51. PubMed ID: 27518757
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of ring-C modified oleanolic acid derivatives and their cytotoxic evaluation.
Pattnaik B; Lakshma Nayak V; Ramakrishna S; Venkata Mallavadhani U
Bioorg Chem; 2016 Oct; 68():152-8. PubMed ID: 27522460
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of betulonic acid derivatives as antitumor agents.
Yang SJ; Liu MC; Zhao Q; Hu DY; Xue W; Yang S
Eur J Med Chem; 2015; 96():58-65. PubMed ID: 25874331
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives.
Liu X; Sun L; Liu QH; Chen BQ; Liu YM
Mini Rev Med Chem; 2020; 20(3):252-257. PubMed ID: 32134368
[TBL] [Abstract][Full Text] [Related]
13. Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; Nain-Perez A; Ferreira SR; Fujiwara RT; de Almeida RM; Heller L; Csuk R
Eur J Med Chem; 2017 Nov; 140():624-635. PubMed ID: 29024910
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cells.
Leal AS; Wang R; Salvador JA; Jing Y
Org Biomol Chem; 2013 Feb; 11(10):1726-38. PubMed ID: 23381885
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
Wang X; Ren QW; Liu XX; Yang YT; Wang BH; Zhai R; Qi JG; Tian JW; Wang HB; Bi Y
Eur J Med Chem; 2019 Jan; 161():364-377. PubMed ID: 30384042
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives.
Liu Q; Liu H; Zhang L; Guo T; Wang P; Geng M; Li Y
Eur J Med Chem; 2013 Jun; 64():1-15. PubMed ID: 23639650
[TBL] [Abstract][Full Text] [Related]
18. Enhancing anticancer activity through the combination of bioreducing agents and triterpenes.
Bednarczyk-Cwynar B; Ruszkowski P; Jarosz T; Krukiewicz K
Future Med Chem; 2018 Mar; 10(5):511-525. PubMed ID: 29424550
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and anti-tumor activity of oleanolic acid derivatives].
Meng YQ; Nie HH; Wang XC; Li D; Ge CX; Zhao N; Chen H; Cao B
Yao Xue Xue Bao; 2011 Oct; 46(10):1215-20. PubMed ID: 22242453
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and antitumor activity of oleanolic acid derivatives.
Meng YQ; Kuai ZY; Zhan SW; Li CL; Chen HR
J Asian Nat Prod Res; 2019 Jul; 21(7):633-651. PubMed ID: 29733221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
